Similar effects were observed in neutrophils from COPD sputum, showing higher potency and efficacy of LAS194046 inhibiting IL-8 and MMP9 release, than fluticasone propionate. The gene discussed is MMP9; the disease is chronic obstructive pulmonary disease.